AVELUMAB

AVELUMAB was reported 4102 times

AVELUMAB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 URETHROSCOPY 2 0.2000
1 AUTOIMMUNE ENDOCRINE DISORDER 3 0.1429
2 ANTI-NEURONAL ANTIBODY POSITIVE 1 0.1429
3 SARCOMATOSIS 2 0.1111
4 PARIETAL LOBE STROKE 3 0.0938
5 ACTH-PRODUCING PITUITARY TUMOUR 1 0.0769
6 BLADDER TRANSITIONAL CELL CARCINOMA METASTATIC 2 0.0690
7 ENDOCRINE TOXICITY 7 0.0686
8 TRANSITIONAL CELL CARCINOMA METASTATIC 8 0.0684
9 PARANEOPLASTIC ENCEPHALOMYELITIS 2 0.0435
10 LYMPHOMA TRANSFORMATION 15 0.0417
11 TUMOUR HYPERPROGRESSION 10 0.0403
12 MYELODYSPLASTIC SYNDROME WITH MULTILINEAGE DYSPLASIA 2 0.0392
13 RADIATION MUCOSITIS 6 0.0373
14 ACUTE ALLOGRAFT NEPHROPATHY 1 0.0370
15 IMMUNE-MEDIATED NEUROLOGICAL DISORDER 3 0.0345
16 AUTOIMMUNE LUNG DISEASE 4 0.0339
17 TRANSFUSION-RELATED CIRCULATORY OVERLOAD 8 0.0331
18 AUTOIMMUNE MYOCARDITIS 7 0.0320
19 HYPOGLOSSAL NERVE PARALYSIS 2 0.0312
20 MALIGNANT GENITOURINARY TRACT NEOPLASM 2 0.0299
21 ABDOMINAL WALL NEOPLASM 1 0.0294
22 ANTIACETYLCHOLINE RECEPTOR ANTIBODY POSITIVE 2 0.0267
23 KL-6 INCREASED 6 0.0265
24 PULMONARY TUMOUR THROMBOTIC MICROANGIOPATHY 2 0.0260
25 CANCER WITH A HIGH TUMOUR MUTATIONAL BURDEN 1 0.0256
26 POLYNEUROPATHY IN MALIGNANT DISEASE 2 0.0244
27 AUTOIMMUNE EYE DISORDER 1 0.0238
28 AUTOIMMUNE CHOLANGITIS 1 0.0227
29 MILLER FISHER SYNDROME 5 0.0223
30 MYOCARDITIS-MYOSITIS-MYASTHENIA GRAVIS OVERLAP SYNDROME 5 0.0219
31 SICCA SYNDROME 4 0.0207
32 ACHROMOTRICHIA ACQUIRED 1 0.0204
33 IMMUNE-MEDIATED NEUROPATHY 3 0.0194
34 SKIN GRAFT FAILURE 2 0.0189
35 ADRENALITIS 2 0.0187
36 AUTOIMMUNE ANAEMIA 1 0.0182
37 IMMUNE-MEDIATED CYSTITIS 2 0.0174
38 PARANEOPLASTIC NEUROLOGICAL SYNDROME 2 0.0156
39 SARCOID-LIKE REACTION 4 0.0155
40 AUTOIMMUNE NEUROPATHY 2 0.0155
41 ANTERIOR CHAMBER CLEAVAGE SYNDROME 1 0.0154
42 RHINOPLASTY 2 0.0153
43 HYPERPLASTIC CHOLECYSTOPATHY 2 0.0148
44 EOSINOPHILIC FASCIITIS 5 0.0144
45 BLOOD CORTICOTROPHIN INCREASED 4 0.0138
46 IMMUNE-MEDIATED ARTHRITIS 5 0.0131
47 RASH FOLLICULAR 2 0.0130
48 PANCREATIC FISTULA 2 0.0130
49 AUTOIMMUNE ARTHRITIS 2 0.0127
50 ANASTOMOTIC FISTULA 1 0.0127
51 SPLENIC ABSCESS 5 0.0123
52 NEUROENDOCRINE CARCINOMA OF THE SKIN 12 0.0123
53 CORONAVIRUS PNEUMONIA 2 0.0120
54 BRCA1 GENE MUTATION 1 0.0114
55 INTERCOSTAL NEURALGIA 2 0.0112
56 BLOOD CORTICOTROPHIN ABNORMAL 1 0.0104
57 METASTASES TO ABDOMINAL WALL 2 0.0101
58 AUTOIMMUNE ENCEPHALOPATHY 1 0.0099
59 IMMUNE-MEDIATED HEPATITIS 20 0.0098
60 ACUTE MOTOR AXONAL NEUROPATHY 1 0.0096
61 GLUCOCORTICOID DEFICIENCY 4 0.0095
62 TUMOUR COMPRESSION 3 0.0094
63 OCULAR MYASTHENIA 3 0.0087
64 MUCOSAL INFECTION 2 0.0085
65 HYPOPHYSITIS 17 0.0084
66 THYROIDITIS 25 0.0083
67 EVANS SYNDROME 4 0.0081
68 INFECTED NEOPLASM 2 0.0080
69 ANTI-THYROID ANTIBODY INCREASED 1 0.0079
70 AUTOIMMUNE PANCREATITIS 4 0.0079
71 ENDOCRINE DISORDER 10 0.0078
72 NEPHRITIS 25 0.0075
73 SKIN TOXICITY 42 0.0074
74 ATRIAL ENLARGEMENT 2 0.0074
75 TUMOUR PSEUDOPROGRESSION 8 0.0073
76 CULTURE STOOL POSITIVE 2 0.0073
77 IMMUNE-MEDIATED RENAL DISORDER 3 0.0072
78 DUODENAL PERFORATION 7 0.0071
79 AUTOIMMUNE NEUTROPENIA 2 0.0069
80 ADRENOCORTICOTROPIC HORMONE DEFICIENCY 6 0.0068
81 VITILIGO 16 0.0068
82 AUTOIMMUNE DERMATITIS 1 0.0066
83 PRIMARY ADRENAL INSUFFICIENCY 2 0.0066
84 IMMUNE-MEDIATED ADVERSE REACTION 10 0.0065
85 BLADDER SPHINCTER ATONY 1 0.0065
86 IMMUNE-MEDIATED NEPHRITIS 3 0.0064
87 AUTOIMMUNE MYOSITIS 3 0.0064
88 ADRENAL DISORDER 12 0.0062
89 AUTOIMMUNE COLITIS 4 0.0062
90 BREAST INJURY 1 0.0061
91 LICHENOID KERATOSIS 14 0.0061
92 FUNGAL SEPSIS 5 0.0060
93 MYOSITIS 54 0.0060
94 FULMINANT TYPE 1 DIABETES MELLITUS 6 0.0058
95 IMMUNE-MEDIATED MYOSITIS 16 0.0058
96 ANAL INJURY 1 0.0058
97 MYOCARDITIS 65 0.0057
98 OXYGEN THERAPY 9 0.0055
99 BLOOD ALKALINE PHOSPHATASE 1 0.0054
100 ACANTHOSIS NIGRICANS 1 0.0054
101 ANAEMIA FOLATE DEFICIENCY 1 0.0052
102 ADRENAL INSUFFICIENCY 62 0.0051
103 IMMUNE-MEDIATED MYOCARDITIS 8 0.0050
104 LICHENIFICATION 2 0.0049
105 HYPOTHALAMO-PITUITARY DISORDER 7 0.0048
106 POLYMYALGIA RHEUMATICA 15 0.0047
107 CUTANEOUS SARCOIDOSIS 2 0.0046
108 NITRITE URINE PRESENT 2 0.0046
109 AUTOIMMUNE NEPHRITIS 1 0.0045
110 CORTISOL DECREASED 5 0.0044
111 AORTITIS 3 0.0044
112 ACUTE MOTOR-SENSORY AXONAL NEUROPATHY 1 0.0043
113 MYASTHENIA GRAVIS 35 0.0043
114 AUTOIMMUNE HYPOTHYROIDISM 1 0.0042
115 HYPERCREATININAEMIA 2 0.0040
116 IMMUNE-MEDIATED DERMATITIS 4 0.0040
117 CENTRAL NERVOUS SYSTEM VASCULITIS 2 0.0039
118 MYASTHENIC SYNDROME 3 0.0039
119 MYOPERICARDITIS 3 0.0038
120 IMMUNE-MEDIATED ENCEPHALITIS 2 0.0038
121 EPIGLOTTITIS 2 0.0037
122 URETERIC OBSTRUCTION 5 0.0037
123 NEOPLASM PROGRESSION 125 0.0036
124 ANAEMIA OF MALIGNANT DISEASE 1 0.0036
125 RADIATION SKIN INJURY 4 0.0034
126 LYMPHATIC DISORDER 2 0.0034
127 MALE SEXUAL DYSFUNCTION 2 0.0033
128 HAEMATOMA MUSCLE 4 0.0033
129 SECONDARY ADRENOCORTICAL INSUFFICIENCY 5 0.0033
130 DISEASE PROGRESSION 386 0.0033
131 ARTHRITIS REACTIVE 2 0.0032
132 TROPONIN T INCREASED 4 0.0032
133 STAPHYLOCOCCAL ABSCESS 2 0.0031
134 RHEUMATIC DISORDER 6 0.0031
135 BLOOD CREATINE PHOSPHOKINASE DECREASED 1 0.0030
136 FASCIITIS 2 0.0030
137 ENCEPHALITIS AUTOIMMUNE 4 0.0030
138 ENCEPHALITIS 21 0.0030
139 BACTERIAL PYELONEPHRITIS 1 0.0030
140 PARANEOPLASTIC SYNDROME 2 0.0030
141 GUILLAIN-BARRE SYNDROME 14 0.0029
142 ADMINISTRATION SITE BRUISE 1 0.0029
143 HYPOPITUITARISM 5 0.0029
144 N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED 4 0.0028
145 SYSTOLIC DYSFUNCTION 3 0.0028
146 NONINFECTIVE ENCEPHALITIS 2 0.0028
147 HYPOTHYROIDISM 88 0.0028
148 PNEUMONITIS 75 0.0028
149 CANCER PAIN 7 0.0027
150 RESPIRATORY TRACT OEDEMA 2 0.0027
151 PULMONARY SARCOIDOSIS 3 0.0027
152 ACUTE PHASE REACTION 1 0.0026
153 BONE TUBERCULOSIS 1 0.0026
154 MYELITIS 4 0.0026
155 HYPERTHYROIDISM 37 0.0026
156 APLASIA 5 0.0026
157 OPHTHALMOPLEGIA 4 0.0025
158 PROCTITIS 7 0.0025
159 GASTROINTESTINAL TOXICITY 12 0.0025
160 PERFORATION 2 0.0025
161 IIIRD NERVE PARALYSIS 2 0.0025
162 GUTTATE PSORIASIS 2 0.0024
163 DENTAL DISCOMFORT 2 0.0024
164 DERMATOMYOSITIS 6 0.0024
165 HEPATITIS 60 0.0023
166 PHYSICAL DECONDITIONING 6 0.0023
167 ANAL SPHINCTER ATONY 1 0.0023
168 OBLITERATIVE BRONCHIOLITIS 3 0.0023
169 HUMERUS FRACTURE 11 0.0023
170 INFUSION RELATED REACTION 148 0.0022
171 IMMUNE-MEDIATED LUNG DISEASE 4 0.0022
172 INTERSTITIAL LUNG DISEASE 106 0.0022
173 IMMUNE THROMBOCYTOPENIA 10 0.0022
174 IMMUNE-MEDIATED ENTEROCOLITIS 8 0.0022
175 PERIPHERAL MOTOR NEUROPATHY 3 0.0021
176 COLITIS 81 0.0021
177 CHOLANGITIS 13 0.0021
178 INTUSSUSCEPTION 2 0.0021
179 CEREBELLAR ATAXIA 2 0.0021
180 ENTEROCOLITIS 12 0.0021
181 BLOOD URIC ACID DECREASED 1 0.0021
182 ACUTE CORONARY SYNDROME 17 0.0021
183 IMMUNE-MEDIATED HEPATIC DISORDER 4 0.0020
184 BLOOD CORTICOTROPHIN DECREASED 1 0.0020
185 DEVICE RELATED THROMBOSIS 2 0.0020
186 RENAL TRANSPLANT FAILURE 2 0.0020
187 RETROPERITONEAL HAEMORRHAGE 5 0.0020
188 DERMATITIS EXFOLIATIVE GENERALISED 7 0.0020
189 ANGIOPLASTY 3 0.0020
190 MENTAL FATIGUE 3 0.0020
191 AUTONOMIC NEUROPATHY 2 0.0020
192 CHOLANGITIS SCLEROSING 4 0.0019
193 DEMYELINATING POLYNEUROPATHY 2 0.0019
194 METASTASES TO PLEURA 2 0.0019
195 BRAIN MIDLINE SHIFT 1 0.0019
196 SARCOIDOSIS 9 0.0019
197 METASTASES TO CENTRAL NERVOUS SYSTEM 24 0.0019
198 GALLBLADDER ENLARGEMENT 2 0.0019
199 PEMPHIGOID 14 0.0019
200 TROPONIN INCREASED 14 0.0018
201 BRONCHOSTENOSIS 1 0.0018
202 TYPE 1 DIABETES MELLITUS 11 0.0018
203 QUADRIPARESIS 3 0.0018
204 ADRENAL HAEMORRHAGE 1 0.0018
205 MYOCARDIAL NECROSIS MARKER INCREASED 3 0.0018
206 MALIGNANT PLEURAL EFFUSION 3 0.0018
207 DUODENAL ULCER HAEMORRHAGE 5 0.0017
208 ENTERITIS 11 0.0017
209 TRANSAMINASES INCREASED 38 0.0017
210 PROCALCITONIN INCREASED 2 0.0017
211 POLYMYOSITIS 3 0.0017
212 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 38 0.0016
213 GASTRIC ULCER HAEMORRHAGE 9 0.0016
214 XEROSIS 2 0.0016
215 EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED 2 0.0016
216 SMALL INTESTINAL PERFORATION 3 0.0016
217 PERIPHERAL SENSORIMOTOR NEUROPATHY 2 0.0016
218 HYPERAESTHESIA TEETH 2 0.0016
219 PULMONARY TOXICITY 11 0.0016
220 PYELONEPHRITIS ACUTE 3 0.0015
221 TUMOUR PAIN 2 0.0015
222 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 4 0.0015
223 INTESTINAL DILATATION 2 0.0015
224 NEOPLASM RECURRENCE 5 0.0015
225 DERMATITIS PSORIASIFORM 3 0.0015
226 SIALOADENITIS 2 0.0015
227 AUTOIMMUNE HAEMOLYTIC ANAEMIA 5 0.0015
228 BILIARY TRACT DISORDER 2 0.0014
229 ANGULAR CHEILITIS 1 0.0014
230 ANASTOMOTIC LEAK 1 0.0014
231 THYROID DISORDER 22 0.0014
232 PERIPHERAL ARTERY THROMBOSIS 2 0.0014
233 MYELITIS TRANSVERSE 2 0.0014
234 POST HERPETIC NEURALGIA 2 0.0014
235 PNEUMONIA PNEUMOCOCCAL 2 0.0013
236 DIVERTICULUM INTESTINAL HAEMORRHAGIC 3 0.0013
237 BASOPHIL COUNT INCREASED 1 0.0013
238 METASTASES TO MENINGES 3 0.0013
239 NEPHROTIC SYNDROME 9 0.0013
240 CYTOMEGALOVIRUS COLITIS 3 0.0013
241 DEVICE RELATED INFECTION 20 0.0013
242 NEURITIS 2 0.0013
243 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 3 0.0013
244 PYELONEPHRITIS 11 0.0013
245 RADIUS FRACTURE 3 0.0012
246 ACUTE PULMONARY OEDEMA 7 0.0012
247 ACUTE LEUKAEMIA 2 0.0012
248 LYMPHADENITIS 3 0.0012
249 ANKYLOSING SPONDYLITIS 16 0.0012
250 ORGANISING PNEUMONIA 6 0.0012
251 HYDRONEPHROSIS 9 0.0012
252 ENTEROBACTER INFECTION 2 0.0012
253 HEPATIC FUNCTION ABNORMAL 44 0.0012
254 FEMALE GENITAL TRACT FISTULA 2 0.0012
255 POLYNEUROPATHY 14 0.0012
256 METASTATIC NEOPLASM 5 0.0012
257 ABDOMINAL LYMPHADENOPATHY 1 0.0012
258 AXONAL NEUROPATHY 1 0.0011
259 SPLENIC INFARCTION 2 0.0011
260 HAEMATURIA 39 0.0011
261 ABDOMINAL SEPSIS 1 0.0011
262 LARYNGEAL OEDEMA 7 0.0011
263 BLOOD ALKALINE PHOSPHATASE ABNORMAL 1 0.0011
264 ARTERIOVENOUS MALFORMATION 1 0.0011
265 CYTOKINE RELEASE SYNDROME 22 0.0011
266 BLOOD THYROID STIMULATING HORMONE ABNORMAL 2 0.0011
267 EYELID PTOSIS 11 0.0011
268 CARDIAC DYSFUNCTION 4 0.0011
269 MUCOSAL INFLAMMATION 28 0.0011
270 IMMUNE THROMBOCYTOPENIC PURPURA 3 0.0011
271 OESOPHAGEAL STENOSIS 3 0.0011
272 BLOOD ALKALINE PHOSPHATASE DECREASED 1 0.0011
273 PROTEINURIA 20 0.0011
274 PNEUMATOSIS INTESTINALIS 3 0.0011
275 TUMOUR HAEMORRHAGE 3 0.0011
276 LYMPHADENOPATHY MEDIASTINAL 2 0.0010
277 RETINAL VEIN OCCLUSION 3 0.0010
278 BLOOD URINE 1 0.0010
279 METASTASES TO LYMPH NODES 7 0.0010
280 DIPLEGIA 2 0.0010
281 CREPITATIONS 3 0.0010
282 AUTOIMMUNE HEPATITIS 7 0.0010
283 HYPOMAGNESAEMIA 14 0.0010
284 BLADDER CANCER RECURRENT 1 0.0010
285 ADMINISTRATION SITE EXTRAVASATION 1 0.0010
286 AZOTAEMIA 4 0.0010
287 ACQUIRED HAEMOPHILIA 1 0.0010
288 BLOOD DISORDER 8 0.0010
289 MIXED LIVER INJURY 3 0.0010
290 DEVICE RELATED SEPSIS 2 0.0010
291 CORONARY ARTERY THROMBOSIS 2 0.0010
292 EMBOLISM VENOUS 3 0.0010
293 HEPATOTOXICITY 22 0.0010
294 KERATITIS 3 0.0010
295 IRITIS 3 0.0010
296 DERMATITIS ACNEIFORM 6 0.0010
297 RENAL HAEMORRHAGE 2 0.0010
298 RECURRENT CANCER 4 0.0010
299 BREAST ABSCESS 1 0.0010
300 OSTEOLYSIS 2 0.0010
301 INTRACARDIAC THROMBUS 3 0.0010
302 PORTAL HYPERTENSION 3 0.0010
303 POLYCYTHAEMIA 2 0.0010
304 PSYCHOTIC SYMPTOM 2 0.0010
305 NEUTROPENIC COLITIS 2 0.0010
306 DERMATITIS BULLOUS 7 0.0010
307 AORTIC DISSECTION 4 0.0010
308 EMBOLISM 8 0.0010
309 FAILURE TO THRIVE 5 0.0010
310 APLASTIC ANAEMIA 5 0.0010
311 URINARY BLADDER HAEMORRHAGE 2 0.0009
312 OPTIC NEUROPATHY 2 0.0009
313 RADIATION PNEUMONITIS 2 0.0009
314 FEBRILE NEUTROPENIA 62 0.0009
315 EXOPHTHALMOS 2 0.0009
316 PORTAL VEIN THROMBOSIS 3 0.0009
317 ARRHYTHMIA SUPRAVENTRICULAR 1 0.0009
318 PERICARDIAL HAEMORRHAGE 2 0.0009
319 CHILLS 107 0.0009
320 DERMATITIS 19 0.0009
321 ELECTROCARDIOGRAM T WAVE INVERSION 2 0.0009
322 MENINGITIS 6 0.0009
323 FEELING COLD 25 0.0009
324 METASTASES TO SPINE 3 0.0009
325 NEPHROPATHY TOXIC 10 0.0009
326 CHOLECYSTITIS ACUTE 5 0.0009
327 HAEMATOCRIT INCREASED 2 0.0009
328 PANCREATITIS NECROTISING 2 0.0009
329 BLOOD THYROID STIMULATING HORMONE INCREASED 8 0.0009
330 UROSEPSIS 8 0.0009
331 ACUTE PRERENAL FAILURE 1 0.0009
332 HAEMOLYTIC URAEMIC SYNDROME 2 0.0009
333 LICHEN PLANUS 2 0.0009
334 RESPIRATORY TRACT INFECTION VIRAL 2 0.0009
335 NEUROPATHY PERIPHERAL 81 0.0009
336 NECROTISING FASCIITIS 3 0.0009
337 CARDIAC TAMPONADE 4 0.0008
338 BILE DUCT STENOSIS 1 0.0008
339 IMMUNE SYSTEM DISORDER 11 0.0008
340 WRIST FRACTURE 10 0.0008
341 LONG QT SYNDROME 2 0.0008
342 PANNICULITIS 2 0.0008
343 SCLERODERMA 3 0.0008
344 FACIAL PARALYSIS 7 0.0008
345 AMYLASE INCREASED 3 0.0008
346 PROTEIN URINE PRESENT 4 0.0008
347 HYPOCALCAEMIA 15 0.0008
348 TASTE DISORDER 16 0.0008
349 CARDIOTOXICITY 7 0.0008
350 BLOOD CREATINE PHOSPHOKINASE MB INCREASED 1 0.0008
351 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 8 0.0008
352 ATRIOVENTRICULAR BLOCK 6 0.0008
353 BILIARY OBSTRUCTION 1 0.0008
354 ACUTE MYELOID LEUKAEMIA 12 0.0008
355 HEPATITIS ACUTE 5 0.0008
356 HYPERGLYCAEMIA 28 0.0008
357 HEPATITIS TOXIC 2 0.0008
358 RADICULOPATHY 2 0.0008
359 POLYARTHRITIS 4 0.0008
360 BLEPHARITIS 3 0.0007
361 TUBULOINTERSTITIAL NEPHRITIS 14 0.0007
362 GENERAL PHYSICAL HEALTH DETERIORATION 86 0.0007
363 GASTRIC PERFORATION 2 0.0007
364 SUBDURAL HAEMORRHAGE 2 0.0007
365 ORAL FUNGAL INFECTION 2 0.0007
366 HYPERURICAEMIA 3 0.0007
367 ILEUS 9 0.0007
368 RASH MORBILLIFORM 2 0.0007
369 SECOND PRIMARY MALIGNANCY 6 0.0007
370 PERICARDITIS 12 0.0007
371 HYPERPYREXIA 3 0.0007
372 NEUTROPENIC SEPSIS 5 0.0007
373 BLADDER TRANSITIONAL CELL CARCINOMA 1 0.0007
374 MYOPATHY 6 0.0007
375 HAEMOTHORAX 2 0.0007
376 THROMBOCYTOPENIA 77 0.0007
377 VASCULITIS 8 0.0007
378 GASTROINTESTINAL NECROSIS 2 0.0007
379 TUMOUR LYSIS SYNDROME 6 0.0007
380 HYPOXIA 24 0.0007
381 BILIARY DILATATION 1 0.0007
382 CARDIOMYOPATHY 10 0.0007
383 HYPOPHOSPHATAEMIA 5 0.0007
384 HEPATITIS FULMINANT 2 0.0007
385 METASTASES TO BONE 11 0.0007
386 INFUSION SITE REACTION 2 0.0007
387 UVEITIS 9 0.0007
388 SQUAMOUS CELL CARCINOMA OF SKIN 4 0.0007
389 SUDDEN DEATH 7 0.0007
390 HYPONATRAEMIA 37 0.0007
391 ASPARTATE AMINOTRANSFERASE ABNORMAL 1 0.0007
392 LUMBAR VERTEBRAL FRACTURE 3 0.0007
393 SMALL INTESTINAL OBSTRUCTION 8 0.0006
394 SPINAL FRACTURE 13 0.0006
395 HYPERCALCAEMIA 8 0.0006
396 PERFORMANCE STATUS DECREASED 3 0.0006
397 OXYGEN SATURATION DECREASED 36 0.0006
398 PEMPHIGUS 8 0.0006
399 PULMONARY HAEMORRHAGE 5 0.0006
400 IRIDOCYCLITIS 2 0.0006
401 BLOOD LACTATE DEHYDROGENASE INCREASED 10 0.0006
402 KIDNEY TRANSPLANT REJECTION 3 0.0006
403 AORTIC VALVE DISEASE 1 0.0006
404 ANAPHYLACTIC SHOCK 16 0.0006
405 LIVER ABSCESS 2 0.0006
406 PANCREATIC DISORDER 3 0.0006
407 INFLAMMATORY MARKER INCREASED 3 0.0006
408 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 2 0.0006
409 MULTIPLE ORGAN DYSFUNCTION SYNDROME 17 0.0006
410 ERYSIPELAS 3 0.0006
411 CEREBRAL HAEMATOMA 2 0.0006
412 KLEBSIELLA INFECTION 3 0.0006
413 CHOLECYSTITIS 7 0.0006
414 PANCREATITIS 31 0.0006
415 ACUTE KIDNEY INJURY 89 0.0006
416 PRIAPISM 2 0.0006
417 MALIGNANT NEOPLASM PROGRESSION 59 0.0006
418 LARGE INTESTINE PERFORATION 4 0.0006
419 NEUROTOXICITY 10 0.0006
420 THROMBOTIC THROMBOCYTOPENIC PURPURA 2 0.0006
421 BREAST CYST 1 0.0006
422 SKIN WEEPING 2 0.0006
423 METASTASIS 4 0.0006
424 HAEMOLYTIC ANAEMIA 5 0.0006
425 ANAL ABSCESS 3 0.0006
426 PYODERMA GANGRENOSUM 2 0.0006
427 BLOOD CREATINE PHOSPHOKINASE INCREASED 16 0.0006
428 BONE LESION 2 0.0006
429 MONOCYTE COUNT INCREASED 2 0.0006
430 SPONDYLITIS 2 0.0005
431 DYSPHONIA 32 0.0005
432 ASPARTATE AMINOTRANSFERASE INCREASED 29 0.0005
433 SEPSIS 60 0.0005
434 ERYTHEMA MULTIFORME 5 0.0005
435 RENAL IMPAIRMENT 45 0.0005
436 PULMONARY ALVEOLAR HAEMORRHAGE 3 0.0005
437 INTESTINAL PERFORATION 6 0.0005
438 ADENOCARCINOMA OF COLON 1 0.0005
439 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 4 0.0005
440 PROTEIN TOTAL DECREASED 2 0.0005
441 TOXIC EPIDERMAL NECROLYSIS 8 0.0005
442 HAEMODYNAMIC INSTABILITY 4 0.0005
443 HYPERTHERMIA 4 0.0005
444 LIPASE INCREASED 4 0.0005
445 ALANINE AMINOTRANSFERASE INCREASED 32 0.0005
446 LIVER DISORDER 23 0.0005
447 HAEMOLYSIS 4 0.0005
448 NEUTROPHIL COUNT DECREASED 21 0.0005
449 LUNG INFECTION 8 0.0005
450 AUTOIMMUNE DISORDER 5 0.0005
451 CARDIOPULMONARY FAILURE 2 0.0005
452 ADRENOCORTICAL INSUFFICIENCY ACUTE 1 0.0005
453 LIVER FUNCTION TEST INCREASED 11 0.0005
454 HAEMORRHAGIC STROKE 4 0.0005
455 METASTASES TO LIVER 9 0.0005
456 BICYTOPENIA 1 0.0005
457 VENOUS THROMBOSIS 2 0.0005
458 LYMPHOCYTE COUNT DECREASED 9 0.0005
459 HYPERTENSION 107 0.0005
460 PNEUMOTHORAX 8 0.0005
461 DIABETIC KETOACIDOSIS 12 0.0005
462 HEPATITIS CHOLESTATIC 3 0.0005
463 SKIN REACTION 7 0.0005
464 CYSTITIS HAEMORRHAGIC 2 0.0005
465 RASH MACULO-PAPULAR 11 0.0005
466 PERIPHERAL VENOUS DISEASE 2 0.0005
467 GOITRE 2 0.0005
468 DEMYELINATION 2 0.0005
469 EXTRAVASATION 2 0.0005
470 ANAPHYLACTOID REACTION 2 0.0005
471 ATRIAL TACHYCARDIA 1 0.0005
472 ALANINE AMINOTRANSFERASE ABNORMAL 1 0.0005
473 HEPATIC CYTOLYSIS 6 0.0005
474 FEBRILE BONE MARROW APLASIA 2 0.0005
475 HYPOPHAGIA 12 0.0005
476 ANAEMIA MACROCYTIC 1 0.0005
477 C-REACTIVE PROTEIN INCREASED 17 0.0005
478 HEPATIC FAILURE 14 0.0005
479 PULMONARY EMBOLISM 44 0.0005
480 HEPATIC LESION 2 0.0005
481 STOMATITIS 28 0.0005
482 ANGINA UNSTABLE 3 0.0005
483 SEPTIC SHOCK 20 0.0005
484 WOUND INFECTION 5 0.0005
485 MELANOCYTIC NAEVUS 2 0.0005
486 GROIN PAIN 4 0.0005
487 PARONYCHIA 2 0.0005
488 GASTROINTESTINAL PAIN 5 0.0005
489 DRUG ERUPTION 8 0.0005
490 EJECTION FRACTION DECREASED 7 0.0004
491 SKIN DISORDER 15 0.0004
492 THERAPY PARTIAL RESPONDER 7 0.0004
493 ATRIOVENTRICULAR BLOCK COMPLETE 3 0.0004
494 MENINGITIS ASEPTIC 2 0.0004
495 URINARY TRACT DISORDER 2 0.0004
496 PLEURAL EFFUSION 27 0.0004
497 PAPILLOEDEMA 2 0.0004
498 SUSPECTED OFF LABEL USE 2 0.0004
499 BLOOD LOSS ANAEMIA 1 0.0004
500 OPTIC NEURITIS 4 0.0004
501 BLOOD PRESSURE SYSTOLIC DECREASED 2 0.0004
502 ABDOMINAL HERNIA 2 0.0004
503 DEATH 377 0.0004
504 ECCHYMOSIS 3 0.0004
505 PNEUMONIA BACTERIAL 4 0.0004
506 LYMPHOEDEMA 3 0.0004
507 PYREXIA 150 0.0004
508 METASTASES TO LUNG 5 0.0004
509 HYPERTRANSAMINASAEMIA 3 0.0004
510 APHONIA 6 0.0004
511 BILIRUBIN CONJUGATED INCREASED 1 0.0004
512 DISSEMINATED INTRAVASCULAR COAGULATION 6 0.0004
513 RESPIRATORY FAILURE 31 0.0004
514 LYMPHOPENIA 6 0.0004
515 HAEMATOTOXICITY 4 0.0004
516 BRONCHOSPASM 6 0.0004
517 URINARY RETENTION 14 0.0004
518 ARTHRITIS 33 0.0004
519 ALTERED STATE OF CONSCIOUSNESS 9 0.0004
520 MYELODYSPLASTIC SYNDROME 6 0.0004
521 DRUG-INDUCED LIVER INJURY 13 0.0004
522 ANAEMIA 78 0.0004
523 RENAL DISORDER 19 0.0004
524 BLOOD BILIRUBIN INCREASED 11 0.0004
525 ACUTE MYOCARDIAL INFARCTION 12 0.0004
526 DIABETES MELLITUS 31 0.0004
527 HOSPICE CARE 4 0.0004
528 HYPERVOLAEMIA 2 0.0004
529 MUCOUS STOOLS 2 0.0004
530 HYPERKALAEMIA 14 0.0004
531 CARDIAC FAILURE 32 0.0004
532 INTESTINAL OBSTRUCTION 15 0.0004
533 AORTIC ANEURYSM 3 0.0004
534 PATHOLOGICAL FRACTURE 2 0.0004
535 ACIDOSIS 3 0.0004
536 PHLEBITIS 2 0.0004
537 NEUTROPENIA 53 0.0004
538 PERICARDIAL EFFUSION 9 0.0004
539 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 10 0.0004
540 AORTIC ARTERIOSCLEROSIS 1 0.0004
541 BLOOD CHLORIDE DECREASED 1 0.0004
542 LUNG DISORDER 19 0.0004
543 HYPERBILIRUBINAEMIA 4 0.0004
544 ACTINIC KERATOSIS 1 0.0004
545 GASTRITIS 10 0.0004
546 BLOOD ALBUMIN DECREASED 3 0.0004
547 PLATELET COUNT DECREASED 40 0.0004
548 AREFLEXIA 1 0.0004
549 HIP FRACTURE 12 0.0004
550 FRACTURE 7 0.0004
551 HYPOKALAEMIA 17 0.0004
552 ASPHYXIA 3 0.0004
553 FAECALOMA 2 0.0004
554 ESCHERICHIA INFECTION 3 0.0004
555 PNEUMONIA ASPIRATION 9 0.0004
556 STEVENS-JOHNSON SYNDROME 8 0.0004
557 ARRHYTHMIA 17 0.0004
558 DECREASED APPETITE 83 0.0004
559 DEVICE OCCLUSION 5 0.0004
560 HEMIPARESIS 6 0.0004
561 HEPATOCELLULAR INJURY 5 0.0004
562 SKIN HYPERPIGMENTATION 3 0.0003
563 EXERCISE TOLERANCE DECREASED 2 0.0003
564 MOUTH SWELLING 2 0.0003
565 BLOOD URIC ACID INCREASED 2 0.0003
566 RALES 2 0.0003
567 GASTROENTERITIS 5 0.0003
568 AUTONOMIC NERVOUS SYSTEM IMBALANCE 1 0.0003
569 PERIPHERAL SENSORY NEUROPATHY 2 0.0003
570 HYPOVOLAEMIA 2 0.0003
571 HYPERTRIGLYCERIDAEMIA 2 0.0003
572 ASCITES 10 0.0003
573 ACUTE RESPIRATORY DISTRESS SYNDROME 6 0.0003
574 COVID-19 PNEUMONIA 4 0.0003
575 ATAXIA 4 0.0003
576 BACTERAEMIA 4 0.0003
577 BLOOD CREATININE INCREASED 22 0.0003
578 PLEURISY 2 0.0003
579 ATYPICAL PNEUMONIA 1 0.0003
580 BONE MARROW DISORDER 1 0.0003
581 PRESYNCOPE 8 0.0003
582 INGUINAL HERNIA 2 0.0003
583 CEREBRAL INFARCTION 8 0.0003
584 CYTOPENIA 4 0.0003
585 TACHYCARDIA 29 0.0003
586 RESPIRATORY DISTRESS 9 0.0003
587 BRAIN NATRIURETIC PEPTIDE INCREASED 1 0.0003
588 PIGMENTATION DISORDER 2 0.0003
589 PANCYTOPENIA 18 0.0003
590 BACTERIAL INFECTION 6 0.0003
591 FLANK PAIN 3 0.0003
592 BLOOD CREATININE DECREASED 1 0.0003
593 ABDOMINAL ADHESIONS 1 0.0003
594 GAMMA-GLUTAMYLTRANSFERASE INCREASED 7 0.0003
595 BILE DUCT STONE 1 0.0003
596 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 3 0.0003
597 HAEMOGLOBIN DECREASED 32 0.0003
598 HAEMOGLOBIN ABNORMAL 2 0.0003
599 DIPLOPIA 8 0.0003
600 THROMBOTIC MICROANGIOPATHY 3 0.0003
601 LOWER RESPIRATORY TRACT INFECTION 14 0.0003
602 RESPIRATORY TRACT INFECTION 8 0.0003
603 APPETITE DISORDER 2 0.0003
604 CARDIAC FAILURE ACUTE 2 0.0003
605 LEUKOPENIA 15 0.0003
606 PNEUMOCYSTIS JIROVECII PNEUMONIA 3 0.0003
607 POSTOPERATIVE WOUND INFECTION 2 0.0003
608 TACHYPNOEA 4 0.0003
609 BODY TEMPERATURE INCREASED 6 0.0003
610 CORONARY ARTERY OCCLUSION 4 0.0003
611 CARDIAC ARREST 24 0.0003
612 RESPIRATION ABNORMAL 2 0.0003
613 BLOOD CREATININE ABNORMAL 1 0.0003
614 ATRIAL FIBRILLATION 28 0.0003
615 FOLLICULITIS 3 0.0003
616 DEFAECATION URGENCY 2 0.0003
617 DEHYDRATION 38 0.0003
618 BRONCHIOLITIS 1 0.0003
619 DUODENAL ULCER 2 0.0003
620 HAEMATEMESIS 7 0.0003
621 CLOSTRIDIUM DIFFICILE INFECTION 6 0.0003
622 ASPIRATION 3 0.0003
623 ASTHMATIC CRISIS 1 0.0003
624 BLOOD PHOSPHORUS DECREASED 1 0.0003
625 OFF LABEL USE 239 0.0003
626 MOUTH HAEMORRHAGE 2 0.0003
627 PNEUMONIA 88 0.0003
628 PSYCHIATRIC SYMPTOM 2 0.0003
629 VENTRICULAR FIBRILLATION 3 0.0003
630 HYPERTENSIVE CRISIS 3 0.0003
631 MALNUTRITION 3 0.0003
632 SKIN INFECTION 3 0.0003
633 KETOACIDOSIS 2 0.0003
634 STATUS EPILEPTICUS 3 0.0003
635 DIARRHOEA 171 0.0003
636 AUTOIMMUNE THYROIDITIS 1 0.0003
637 BRADYCARDIA 14 0.0003
638 ACUTE RESPIRATORY FAILURE 5 0.0003
639 SYNCOPE 26 0.0003
640 DELIRIUM 9 0.0003
641 TREMOR 43 0.0003
642 HYPOALBUMINAEMIA 2 0.0003
643 NERVOUS SYSTEM DISORDER 8 0.0003
644 SPINAL PAIN 3 0.0003
645 ELECTROCARDIOGRAM ABNORMAL 2 0.0003
646 CYANOSIS 4 0.0003
647 LYMPHADENOPATHY 9 0.0003
648 GINGIVAL PAIN 2 0.0003
649 HAEMOPTYSIS 7 0.0003
650 ARTERIOSPASM CORONARY 1 0.0002
651 STENT PLACEMENT 2 0.0002
652 BACK PAIN 57 0.0002
653 ENCEPHALOPATHY 6 0.0002
654 ARTHRITIS BACTERIAL 1 0.0002
655 BLOOD PRESSURE INCREASED 37 0.0002
656 PERITONITIS 5 0.0002
657 HEMIPLEGIA 2 0.0002
658 EOSINOPHIL COUNT INCREASED 2 0.0002
659 BLOOD UREA INCREASED 4 0.0002
660 UPPER GASTROINTESTINAL HAEMORRHAGE 4 0.0002
661 BRAIN OEDEMA 3 0.0002
662 CANDIDA INFECTION 4 0.0002
663 HYPOTENSION 47 0.0002
664 RESPIRATORY DISORDER 7 0.0002
665 RASH 102 0.0002
666 RENAL FAILURE 31 0.0002
667 ATRIOVENTRICULAR BLOCK FIRST DEGREE 1 0.0002
668 ORAL CANDIDIASIS 3 0.0002
669 BLOOD CREATINE INCREASED 1 0.0002
670 ISCHAEMIC STROKE 4 0.0002
671 PULMONARY OEDEMA 10 0.0002
672 ORAL PAIN 5 0.0002
673 GASTROINTESTINAL DISORDER 20 0.0002
674 BLOOD THYROID STIMULATING HORMONE DECREASED 1 0.0002
675 HEPATIC ENZYME INCREASED 15 0.0002
676 MUSCULAR WEAKNESS 25 0.0002
677 GINGIVAL BLEEDING 3 0.0002
678 SKIN LESION 6 0.0002
679 BRAIN NEOPLASM 2 0.0002
680 RESPIRATORY ARREST 6 0.0002
681 SHOCK 5 0.0002
682 BLOOD PRESSURE DIASTOLIC INCREASED 1 0.0002
683 BLOOD CHOLESTEROL ABNORMAL 1 0.0002
684 MENTAL STATUS CHANGES 6 0.0002
685 NEPHROPATHY 2 0.0002
686 VERTIGO 13 0.0002
687 HEPATIC CIRRHOSIS 4 0.0002
688 BLOOD SODIUM DECREASED 4 0.0002
689 DYSPHAGIA 20 0.0002
690 BLOOD PRESSURE DECREASED 14 0.0002
691 GASTRIC ULCER 4 0.0002
692 ECZEMA 11 0.0002
693 SUBDURAL HAEMATOMA 3 0.0002
694 SUPRAVENTRICULAR TACHYCARDIA 2 0.0002
695 GLAUCOMA 4 0.0002
696 ATELECTASIS 2 0.0002
697 INFLAMMATORY BOWEL DISEASE 2 0.0002
698 RASH PRURITIC 11 0.0002
699 HAEMATOCRIT DECREASED 4 0.0002
700 ABDOMINAL TENDERNESS 1 0.0002
701 BLOOD ALKALINE PHOSPHATASE INCREASED 5 0.0002
702 DEEP VEIN THROMBOSIS 13 0.0002
703 EMPHYSEMA 2 0.0002
704 DYSPNOEA 111 0.0002
705 AMMONIA INCREASED 1 0.0002
706 CEREBRAL HAEMORRHAGE 7 0.0002
707 CACHEXIA 1 0.0002
708 MUSCULOSKELETAL CHEST PAIN 3 0.0002
709 BENIGN PROSTATIC HYPERPLASIA 1 0.0002
710 HAEMATOMA 5 0.0002
711 CLOSTRIDIUM DIFFICILE COLITIS 2 0.0002
712 SENSORY DISTURBANCE 3 0.0002
713 DRY MOUTH 15 0.0002
714 PRODUCT PRESCRIBING ISSUE 4 0.0002
715 OESOPHAGITIS 2 0.0002
716 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 10 0.0002
717 ASTHENOPIA 1 0.0002
718 MELAENA 4 0.0002
719 VENTRICULAR TACHYCARDIA 3 0.0002
720 DIVERTICULITIS 5 0.0002
721 COAGULOPATHY 3 0.0002
722 CONSTIPATION 39 0.0002
723 CELLULITIS 9 0.0002
724 BLOOD CALCIUM DECREASED 2 0.0002
725 MITRAL VALVE INCOMPETENCE 2 0.0002
726 CIRCULATORY COLLAPSE 3 0.0002
727 URINARY TRACT INFECTION 30 0.0002
728 FATIGUE 136 0.0002
729 ANGINA PECTORIS 5 0.0002
730 GASTRIC HAEMORRHAGE 2 0.0002
731 MALAISE 76 0.0002
732 ORTHOSTATIC HYPOTENSION 3 0.0002
733 ELECTROLYTE IMBALANCE 2 0.0002
734 THIRST 3 0.0002
735 RHABDOMYOLYSIS 7 0.0002
736 MYOCLONUS 2 0.0002
737 ABDOMINAL PAIN 39 0.0002
738 CARDIO-RESPIRATORY ARREST 7 0.0002
739 CONFUSIONAL STATE 27 0.0002
740 MYELOSUPPRESSION 6 0.0002
741 SEIZURE 19 0.0002
742 DYSURIA 6 0.0002
743 LIVER INJURY 4 0.0002
744 ANAPHYLACTIC REACTION 9 0.0002
745 HYPERSENSITIVITY 30 0.0002
746 DYSARTHRIA 6 0.0002
747 MUSCLE ATROPHY 2 0.0002
748 CARDIOVASCULAR DISORDER 4 0.0002
749 CYSTITIS 5 0.0002
750 HERPES ZOSTER 9 0.0002
751 CHOLESTASIS 3 0.0002
752 CONDITION AGGRAVATED 47 0.0002
753 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 8 0.0002
754 MYALGIA 26 0.0002
755 BLOOD PRESSURE ABNORMAL 3 0.0002
756 ADVERSE REACTION 2 0.0002
757 MALIGNANT MELANOMA 2 0.0001
758 VOMITING 70 0.0001
759 JAUNDICE 4 0.0001
760 FEEDING DISORDER 3 0.0001
761 BONE MARROW FAILURE 3 0.0001
762 PALLOR 4 0.0001
763 ACUTE HEPATIC FAILURE 2 0.0001
764 BLOOD TESTOSTERONE DECREASED 1 0.0001
765 RIB FRACTURE 3 0.0001
766 CENTRAL NERVOUS SYSTEM LESION 2 0.0001
767 ASTHENIA 54 0.0001
768 HEART RATE DECREASED 5 0.0001
769 BLOOD TEST ABNORMAL 2 0.0001
770 SYSTEMIC LUPUS ERYTHEMATOSUS 5 0.0001
771 SINUS TACHYCARDIA 2 0.0001
772 PRURITUS 54 0.0001
773 RED BLOOD CELL COUNT DECREASED 4 0.0001
774 CARDIOGENIC SHOCK 2 0.0001
775 NAUSEA 110 0.0001
776 LIVER FUNCTION TEST ABNORMAL 4 0.0001
777 PRODUCT USE IN UNAPPROVED INDICATION 34 0.0001
778 APATHY 2 0.0001
779 BONE PAIN 8 0.0001
780 LABORATORY TEST ABNORMAL 4 0.0001
781 CHEST PAIN 25 0.0001
782 PULMONARY MASS 2 0.0001
783 HAEMORRHAGE 14 0.0001
784 RASH PAPULAR 3 0.0001
785 HAEMORRHAGE INTRACRANIAL 2 0.0001
786 SPEECH DISORDER 7 0.0001
787 THERAPY NON-RESPONDER 6 0.0001
788 APHASIA 4 0.0001
789 UNEVALUABLE EVENT 10 0.0001
790 EPILEPSY 4 0.0001
791 BOWEL MOVEMENT IRREGULARITY 1 0.0001
792 UPPER RESPIRATORY TRACT INFECTION 6 0.0001
793 TENDONITIS 2 0.0001
794 APHTHOUS ULCER 1 0.0001
795 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 1 0.0001
796 BASAL CELL CARCINOMA 2 0.0001
797 HAEMATOCHEZIA 7 0.0001
798 ULCER 2 0.0001
799 SCIATICA 2 0.0001
800 ATRIAL FLUTTER 1 0.0001
801 METABOLIC ACIDOSIS 4 0.0001
802 LOSS OF CONSCIOUSNESS 16 0.0001
803 INFECTION 18 0.0001
804 NEURALGIA 3 0.0001
805 BLOOD POTASSIUM INCREASED 2 0.0001
806 OEDEMA PERIPHERAL 15 0.0001
807 EYE DISORDER 4 0.0001
808 PHOTOSENSITIVITY REACTION 2 0.0001
809 AGEUSIA 3 0.0001
810 HOT FLUSH 9 0.0001
811 ADVERSE EVENT 11 0.0001
812 TYPE 2 DIABETES MELLITUS 4 0.0001
813 FACE OEDEMA 2 0.0001
814 CEREBROVASCULAR ACCIDENT 20 0.0001
815 ANURIA 1 0.0001
816 BLOOD MAGNESIUM DECREASED 1 0.0001
817 RHEUMATOID ARTHRITIS 13 0.0001
818 RASH MACULAR 4 0.0001
819 EOSINOPHILIA 2 0.0001
820 BLOOD CALCIUM INCREASED 1 0.0001
821 GALLBLADDER DISORDER 2 0.0001
822 GOUT 2 0.0001
823 OEDEMA 6 0.0001
824 LEUKOCYTOSIS 2 0.0001
825 OSTEOMYELITIS 2 0.0001
826 MYOCARDIAL INFARCTION 19 0.0001
827 FLUSHING 11 0.0001
828 CONJUNCTIVITIS 2 0.0001
829 MIDDLE INSOMNIA 2 0.0001
830 COGNITIVE DISORDER 5 0.0001
831 APPENDICITIS 1 0.0001
832 CARDIAC DISORDER 10 0.0001
833 BLISTER 6 0.0001
834 ARTERIOSCLEROSIS 1 0.0001
835 FOOT FRACTURE 2 0.0001
836 MUSCULOSKELETAL DISORDER 2 0.0001
837 RASH ERYTHEMATOUS 5 0.0001
838 PULMONARY FIBROSIS 2 0.0001
839 LOWER LIMB FRACTURE 2 0.0001
840 COUGH 29 0.0001
841 HYPOGLYCAEMIA 5 0.0001
842 BLOOD PRESSURE SYSTOLIC INCREASED 2 0.0001
843 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 3 0.0001
844 KIDNEY INFECTION 2 0.0001
845 ALOPECIA 20 0.0001
846 WHEEZING 6 0.0001
847 BLOOD POTASSIUM DECREASED 3 0.0001
848 FLUID RETENTION 5 0.0001
849 INFLAMMATION 5 0.0001
850 PULMONARY HYPERTENSION 2 0.0001
851 HEAD INJURY 3 0.0001
852 PALPITATIONS 11 0.0001
853 EPISTAXIS 7 0.0001
854 MOVEMENT DISORDER 3 0.0001
855 BREAST CANCER METASTATIC 1 0.0001
856 LACTIC ACIDOSIS 3 0.0001
857 ERYTHEMA 19 0.0001
858 FAECES DISCOLOURED 2 0.0001
859 CHRONIC KIDNEY DISEASE 7 0.0001
860 STAPHYLOCOCCAL INFECTION 3 0.0001
861 GAIT INABILITY 3 0.0001
862 DIZZINESS 44 0.0001
863 HYPERHIDROSIS 11 0.0001
864 BLOOD IRON DECREASED 1 0.0001
865 GASTROINTESTINAL HAEMORRHAGE 7 0.0001
866 TOXICITY TO VARIOUS AGENTS 14 0.0001
867 WEIGHT DECREASED 23 0.0001
868 ARTHRALGIA 34 0.0001
869 FEELING HOT 5 0.0001
870 BRONCHITIS 6 0.0001
871 OSTEONECROSIS OF JAW 2 0.0001
872 CHEST DISCOMFORT 8 0.0001
873 UNRESPONSIVE TO STIMULI 2 0.0001
874 SKIN ULCER 2 0.0001
875 PSORIASIS 10 0.0001
876 BEDRIDDEN 1 0.0001
877 FALL 25 0.0001
878 CARDIAC FAILURE CONGESTIVE 6 0.0001
879 PAIN OF SKIN 2 0.0001
880 PSORIATIC ARTHROPATHY 3 0.0001
881 WHITE BLOOD CELL COUNT DECREASED 8 0.0001
882 BLINDNESS 3 0.0001
883 INFLUENZA LIKE ILLNESS 6 0.0001
884 DRUG INTOLERANCE 7 0.0001
885 HOSPITALISATION 11 0.0001
886 DYSPEPSIA 7 0.0001
887 SKIN EXFOLIATION 6 0.0001
888 OSTEOARTHRITIS 3 0.0001
889 THERAPY INTERRUPTED 5 0.0001
890 HYPERSOMNIA 2 0.0001
891 MOBILITY DECREASED 5 0.0001
892 SOMNOLENCE 14 0.0001
893 LETHARGY 4 0.0001
894 PANCREATIC CARCINOMA 2 0.0001
895 DYSSTASIA 2 0.0001
896 DYSGEUSIA 5 0.0001
897 ABDOMINAL DISTENSION 7 0.0001
898 THROAT IRRITATION 3 0.0001
899 CONTRAINDICATED PRODUCT ADMINISTERED 2 0.0001
900 BLOOD COUNT ABNORMAL 1 0.0001
901 TINNITUS 3 0.0001
902 PERIPHERAL SWELLING 10 0.0001
903 DISEASE RECURRENCE 3 0.0001
904 THROMBOSIS 5 0.0001
905 BACK DISORDER 1 0.0001
906 CHOLELITHIASIS 2 0.0001
907 HEART RATE INCREASED 6 0.0001
908 FUNGAL INFECTION 2 0.0001
909 TRANSIENT ISCHAEMIC ATTACK 2 0.0001
910 MUSCULOSKELETAL PAIN 3 0.0001
911 INTENTIONAL PRODUCT USE ISSUE 5 0.0001
912 BLOOD TRIGLYCERIDES INCREASED 1 0.0001
913 DISTURBANCE IN ATTENTION 3 0.0001
914 ELECTROCARDIOGRAM QT PROLONGED 2 0.0001
915 PAIN 34 0.0001
916 BONE DISORDER 1 0.0001
917 RESTLESSNESS 2 0.0001
918 BLOOD GLUCOSE ABNORMAL 1 0.0001
919 MEDICATION ERROR 3 0.0001
920 AGRANULOCYTOSIS 1 0.0001
921 EYE SWELLING 2 0.0001
922 URTICARIA 9 0.0001
923 NECK PAIN 3 0.0001
924 HYPOAESTHESIA 8 0.0001
925 SWELLING 5 0.0001
926 DYSPNOEA EXERTIONAL 2 0.0001
927 ANXIETY 15 0.0001
928 BLOOD URINE PRESENT 1 0.0001
929 SURGERY 3 0.0001
930 DEPRESSED LEVEL OF CONSCIOUSNESS 2 0.0001
931 WEIGHT INCREASED 11 0.0000
932 POLLAKIURIA 2 0.0000
933 GAIT DISTURBANCE 9 0.0000
934 RECTAL HAEMORRHAGE 2 0.0000
935 HYPOACUSIS 2 0.0000
936 HEADACHE 29 0.0000
937 COVID-19 8 0.0000
938 DRY SKIN 6 0.0000
939 INFLUENZA 5 0.0000
940 COLITIS ULCERATIVE 2 0.0000
941 ADVERSE DRUG REACTION 4 0.0000
942 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 8 0.0000
943 PAIN IN EXTREMITY 13 0.0000
944 DEPRESSION 10 0.0000
945 MUSCLE SPASMS 8 0.0000
946 BLOOD CHOLESTEROL INCREASED 2 0.0000
947 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 3 0.0000
948 PRODUCTIVE COUGH 2 0.0000
949 BLOOD PRESSURE FLUCTUATION 1 0.0000
950 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 2 0.0000
951 ABDOMINAL PAIN LOWER 1 0.0000
952 DRUG INEFFECTIVE 52 0.0000
953 SINUSITIS 4 0.0000
954 APPLICATION SITE ERYTHEMA 1 0.0000
955 DERMATITIS ATOPIC 2 0.0000
956 DEPRESSED MOOD 2 0.0000
957 FEELING ABNORMAL 9 0.0000
958 GASTROOESOPHAGEAL REFLUX DISEASE 3 0.0000
959 IRRITABILITY 2 0.0000
960 ILL-DEFINED DISORDER 2 0.0000
961 OROPHARYNGEAL PAIN 3 0.0000
962 AMNESIA 2 0.0000
963 SWELLING FACE 2 0.0000
964 NEOPLASM MALIGNANT 2 0.0000
965 ILLNESS 3 0.0000
966 SLEEP DISORDER 2 0.0000
967 SKIN BURNING SENSATION 2 0.0000
968 HALLUCINATION 2 0.0000
969 INSOMNIA 7 0.0000
970 PARAESTHESIA 4 0.0000
971 ABNORMAL BEHAVIOUR 1 0.0000
972 ABDOMINAL PAIN UPPER 5 0.0000
973 VISUAL IMPAIRMENT 3 0.0000
974 TREATMENT FAILURE 2 0.0000
975 PRODUCT STORAGE ERROR 2 0.0000
976 ANGIOEDEMA 1 0.0000
977 MEMORY IMPAIRMENT 3 0.0000
978 PRODUCT USE ISSUE 4 0.0000
979 DRUG INTERACTION 3 0.0000
980 ARTHROPATHY 1 0.0000
981 ABDOMINAL DISCOMFORT 3 0.0000
982 EMOTIONAL DISTRESS 2 0.0000
983 NASOPHARYNGITIS 3 0.0000
984 BLOOD GLUCOSE INCREASED 3 0.0000
985 VISION BLURRED 2 0.0000
986 AGITATION 1 0.0000
987 PRODUCT DOSE OMISSION ISSUE 4 0.0000
988 BALANCE DISORDER 1 0.0000
989 NO ADVERSE EVENT 2 0.0000
990 OVERDOSE 2 0.0000